 |
Play Video: The Importance of Insider Buying
|
|
 |
The table below summarizes the most recent SVRA insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why SVRA insider buys are important for investors to follow.
Date | Insider | Price | Amount |
11-19-2024 Insider Buy |
Joseph S. McCracken
|
$2.95
CAGR »
|
$59,072.00 20,000 shares |
11-18-2024 Insider Buy |
David A. Ramsay
|
$2.88
CAGR »
|
$287,600.00 100,000 shares |
7-17-2023 Insider Buy |
Growth Equity Opportunities 17, LLC >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Forest Baskett >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Ali Behbahani >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Carmen Chang >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Anthony A. Florence Jr. >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Mohamad Makhzoumi >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Edward T. Mathers >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Scott D. Sandell >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Paul Edward Walker >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
7-17-2023 Insider Buy |
Rick Yang >10% Owner |
$3.00
CAGR »
|
$999,999.00 333,333 shares |
6-26-2023 Insider Buy |
Raymond Dennis Pratt Chief Medical Officer |
$2.93
CAGR »
|
$19,045.00 6,500 shares |
5-26-2023 Insider Buy |
David A. Ramsay Director |
$2.59
CAGR »
|
$258,528.94 100,000 shares |
12-30-2022 Insider Buy |
David A. Ramsay Director |
$1.54
CAGR »
|
$55,586.00 36,000 shares |
12-28-2022 Insider Buy |
David A. Ramsay Director |
$1.45
CAGR »
|
$27,588.24 19,000 shares |
12-22-2022 Insider Buy |
David A. Ramsay Director |
$1.48
CAGR »
|
$66,434.34 45,000 shares |
12-22-2022 Insider Buy |
Raymond Dennis Pratt Chief Medical Officer |
$1.54
CAGR »
|
$5,401.90 3,500 shares |
12-20-2022 Insider Buy |
David A. Ramsay Director |
$1.50
CAGR »
|
$82,104.52 54,890 shares |
11-23-2022 Insider Buy |
David A. Ramsay Director |
$1.43
CAGR »
|
$28,652.19 20,105 shares |
9-27-2022 Insider Buy |
David A. Ramsay Director |
$1.39
CAGR »
|
$187,093.28 135,000 shares |
9-20-2022 Insider Buy |
David A. Ramsay Director |
$1.45
CAGR »
|
$11,561.80 8,000 shares |
9-8-2022 Insider Buy |
David A. Ramsay Director |
$1.40
CAGR »
|
$44,721.65 32,000 shares |
9-1-2022 Insider Buy |
David A. Ramsay Director |
$1.42
CAGR »
|
$141,931.84 100,000 shares |
6-22-2022 Insider Buy |
David A. Ramsay Director |
$1.38
CAGR »
|
$138,380.08 100,000 shares |
12-30-2021 Insider Buy |
David A. Ramsay Director |
$1.28
CAGR »
|
$64,035.00 50,000 shares |
12-17-2021 Insider Buy |
David L. Lowrance CHIEF FINANCIAL OFFICER |
$1.14
CAGR »
|
$4,568.80 4,000 shares |
12-17-2021 Insider Buy |
David A. Ramsay Director |
$1.11
CAGR »
|
$44,485.00 40,000 shares |
12-10-2021 Insider Buy |
David A. Ramsay Director |
$1.04
CAGR »
|
$36,365.00 35,000 shares |
12-8-2021 Insider Buy |
David A. Ramsay Director |
$1.05
CAGR »
|
$26,214.47 25,000 shares |
12-9-2021 Insider Buy |
Badrul A. Chowdhury CHIEF MEDICAL OFFICER |
$1.05
CAGR »
|
$26,250.00 25,000 shares |
12-8-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.06
CAGR »
|
$6,889.35 6,500 shares |
12-2-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.10
CAGR »
|
$10,954.00 10,000 shares |
12-1-2021 Insider Buy |
David A. Ramsay Director |
$1.09
CAGR »
|
$27,157.00 25,000 shares |
11-19-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.10
CAGR »
|
$24,389.75 22,150 shares |
11-22-2021 Insider Buy |
David A. Ramsay Director |
$1.08
CAGR »
|
$215,392.60 200,000 shares |
9-30-2021 Insider Buy |
David A. Ramsay Director |
$1.29
CAGR »
|
$176,381.82 137,052 shares |
8-18-2021 Insider Buy |
David A. Ramsay Director |
$1.18
CAGR »
|
$115,180.95 97,290 shares |
5-21-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.63
CAGR »
|
$16,298.00 10,000 shares |
4-19-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.82
CAGR »
|
$49,870.74 27,400 shares |
3-22-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$2.07
CAGR »
|
$49,937.61 24,100 shares |
3-15-2021 Insider Buy |
Joseph S. McCracken Director |
$1.45
CAGR »
|
$99,999.25 68,965 shares |
3-15-2021 Insider Buy |
David L. Lowrance CHIEF FINANCIAL OFFICER |
$1.45
CAGR »
|
$19,999.85 13,793 shares |
3-15-2021 Insider Buy |
David A. Ramsay Director |
$1.45
CAGR »
|
$999,999.75 689,655 shares |
2-22-2021 Insider Buy |
Matthew Pauls CHIEF EXECUTIVE OFFICER |
$1.74
CAGR »
|
$50,038.45 28,700 shares |
6-28-2019 Insider Buy |
David A. Ramsay Director |
$2.37
CAGR »
|
$138,224.95 58,357 shares |
6-18-2019 Insider Buy |
David A. Ramsay Director |
$2.37
CAGR »
|
$95,355.25 40,215 shares |
12-21-2018 Insider Buy |
Robert N. Neville Chief Executive Officer |
$6.38
CAGR »
|
$149,993.78 23,517 shares |
3-29-2018 Insider Buy |
Yuri Pikover Director |
$9.00
CAGR »
|
$33,603.01 3,734 shares |
10-27-2017 Insider Buy |
Yuri Pikover Director |
$7.85
CAGR »
|
$392,500.00 50,000 shares |
6-7-2017 Insider Buy |
Joseph S. McCracken Director |
$4.75
CAGR »
|
$248,187.50 52,250 shares |
6-7-2017 Insider Buy |
David L. Lowrance Chief Financial Officer |
$4.75
CAGR »
|
$9,975.00 2,100 shares |
6-7-2017 Insider Buy |
Jaakko Taneli Jouhikainen See Remarks |
$4.75
CAGR »
|
$49,875.00 10,500 shares |
6-7-2017 Insider Buy |
Yuri Pikover Director |
$4.75
CAGR »
|
$475,000.00 100,000 shares |
6-7-2017 Insider Buy |
David A. Ramsay Director |
$4.75
CAGR »
|
$99,750.00 21,000 shares |
6-7-2017 Insider Buy |
Robert N. Neville Chief Executive Officer |
$4.75
CAGR »
|
$248,187.50 52,250 shares |
Also See: Institutional Holders of SVRA
Also See: SEC filings
Below we present the annualized performance delivered by SVRA stock since 11-19-2024 (the date of the most recent
insider purchase). The performance of the investment from the time SVRA insider buying occurred is the ultimate
test of whether insiders were right about SVRA being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/20/2024 |
|
End date: |
03/21/2025 |
|
Start price/share: |
$3.13 |
|
End price/share: |
$2.82 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-9.90% |
|
Annualized Gain: |
-30.13% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,010.00 |
|
Years: |
0.33 |
|
SVRA Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent SVRA insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding SVRA
|
 |